Newsletter registration

By using our website, you are agreeing to cookies being stored and Google Analytics being used on your device in order to offer the best possible service. You can find more information on thishere.
Austria.
Dynamic Business Location.

Oral vaccination for type 1 diabetes may be possible

In the case of type 1 diabetes, the autoimmune response against the insulin-producing cells in the pancreas leads to an outbreak of the illness.   An international group of scientists including doctors from the University Pediatric Clinic in Vienna investigated a type of prophylactic vaccine against diabetes. The results were positive, as reported in the American medical journal “JAMA”.

"In this study with children with a high risk of developing type 1 diabetes, the oral administration of 67.5 milligrams of insulin once per day compared to a placebo led to an immune response without the corresponding development of low blood sugar. The results show that a Phase III study (note: effectiveness) would be recommended in order to determine whether insulin can prevent the autoimmune response against the islet cells and thus diabetes in such children”, said  Ezio Bonifacio of the Center for Regenerative Meidince at the Dresden University of Technology and his co-authors in summarizing the results of the study.   

The publication is a so-called pre-POINT study, involving the Center for Childhood Diabetes at the University of Colorado (Denver, USA), Southmead Hospital (Bristol, UK), the University Pediatric Clinic at Vienna General Hospital (Medical University of Vienna), the research facility in Dresden and the Institute for Diabetes Research of the Munich University of Technology. The specialists Edith Schober and Birgit Rami from Vienna participated in the project.

The work could be pioneering, according to Anette-Gabriele Ziegler of the Institute for Diabetes Research in Munich. The attempt to develop a prophylactic vaccine to prevent autoimmune responses triggering “juvenile diabetes” is unique. “This is a revolutionary approach to prevent type 1 diabetes“, she said. A more extensive study to precisely clarify the effectiveness of this approach is planned.  In this case, the plan is to target families in which type 1 diabetes often occurs. 

Share on Facebook Share on Facebook Share on Twitter Share on Twitter Share on Linkedin Share on Linkedin

Testimonials

Events

Meet us at events, seminars and trade shows - worldwide.

  • Specialist seminar Invest in Austria "Research and foundation of companies in Austria"

    29.01.2019, Zürich, Schweiz

Austria Map

Find the perfect location for your company

One of Austria's key strengths as a business destination is its highly qualified and motivated skilled workforce for research and development, especially in the scientific sector.

Nestlé Austria

Logo
More testimonials

news from the business location Austria

Medical University of Vienna: New therapy option doubles the life span of B-cell lymphoma patients

The so-called CAR-T cell therapy is a promising option for treating around one fifth of patients with diffuse large B-cell lymphoma.

Ski Tourism as an Attractive Business Driver in Austria

Famous for its culture and unspoiled natural environment, Austria attracts vacationers and tourism companies from all over the world. One major advantage is the central location in the heart of Europe and the related good accessibility.

More news All blog posts